Second-line Chemotherapy for Advanced Bladder Cancer: Taxanes Versus Vinflunine

Aim: Second-line chemotherapy in advanced urothelial carcinoma (UC) remains a significant clinical challenge, with limited high-level evidence guiding regimen selection. Vinflunine is the only agent approved by the European Medicines Agency for this setting, while taxanes are widely used off-label b...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Bilgin Demir, Ali Aytaç, Gökhan Çolak, Onur Yazdan Balçık, Ömer Acar
Format:	Artigo
Jezik:	Inglês
Izdano:	Ankara Hematology Oncology Association 2025-08-01
Serija:	Acta Haematologica Oncologica Turcica
Teme:	urothelial carcinoma second-line chemotherapy taxanes vinflunine
Online dostop:	https://www.actaoncologicaturcica.com/articles/second-line-chemotherapy-for-advanced-bladder-cancer-taxanes-versus-vinflunine/doi/ahot.galenos.2025.2025-7-2
Oznake:	Označite Brez oznak, prvi označite!